Who Paid My Doc
(14C)-CV010 - A Phase I, Open-Label Study of the Absorption, Metabolism and Excretion Following a Single Oral Dose to Healthy Male Subjects
ClinicalTrials.gov NCT03210909
Research payments
$100,435
Through program year 2020, $100,435 in research payments was reported against (14C)-CV010 - A Phase I, Open-Label Study of the Absorption, Metabolism and Excretion Following a Single Oral Dose to Healthy Male Subjects, across 1 payment, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- NCT03210909
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $100,435 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
1 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.